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72Se/72As. An important research strand is also devoted to the 
alternative (in opposition to the classical reactor route via 
99Mo generator) accelerator production method of the most 
popular nuclear medicine radioisotope, 99mTc. The research 
on accelerator produced medical radioisotopes based on the 
HIL cyclotrons is conducted within a large collaboration, 
involving the Heavy Ion Laboratory, the University of Silesia, 
the Institute of Nuclear Chemistry and Technology (INCT), 
POLATOM at the National Centre for Nuclear Research, the 
Centre of Biological and Chemical Research of the University 
of Warsaw and the Institute of Nuclear Physics in Kraków. 
After target preparation and irradiation the properties of the 
produced radioisotopes are first investigated at HIL via 
gamma-ray spectroscopy techniques and subsequently 
transported to INCT or POLATOM for further chemical 
investigations. Table below shows some of the obtained 
results. 
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The 44Sc isomeric pair has attracted a lot of attention in 
recent years as a candidate for various applications in 
nuclear medicine [1-6]. Colloquially speaking, this pair can 
be considered as an “ARRONAX” isotope, with applications in 
Three Photon PET techniques already suggested in 2007[1], 
and the 58 h high spin (6+) isomeric state, decaying by 99% IT 
to the 4 h (2+) ground state, as an in vivo generator discussed 
recently in Refs [4-6]. This ground state undergoes in turn 
predominantly the β+ decay to the 1157 keV excited state in 
44Ca. The previously investigated production of 44mSc using 
the deuteron beams is extended to alpha particle projectiles 
in the present work. It is well known that due to its larger 
mass and higher bombarding energy, the alpha particle 
transfers to the compound nucleus a larger angular 
momentum than lighter projectiles. Although the production 
efficiency (Thick Target Yield) of the high spin isomer is not 
much augmented with this projectile, the isomeric ratio is 
substantially increased (from 2.2% up to 10.9%, see table 
below) which should allow this isomer to be produced with a 
much lower contribution of the directly formed ground state 
decay; as discussed in previous references, this is very 
important for synthesis of the in vivo 44Sc generator. 
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TABLE I 
Thick Target Yield of 44gdSc (42CaCO3 or 41KCl targets) and the 
ratio of TTY of 44mSc/44gdSc for p, d and α projectiles 
estimated from Refs. 2-5 and the present work. 
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Purpose: Personalized medicine is greatly facilitated by 
predictive models. In order to successfully train predictive 
models, large volumes of patient data are required. These 
data are readily available from hospitals worldwide, 
however, sharing these data is hampered by ethical, 
political, administrative and legal boundaries. A method by 
which these boundaries can be circumvented is distributed 
learning. In a distributed learning approach, the model 
application is sent to each individual hospital that contains 
data. The model learns from the data at the hospital. 
Subsequently, the models are sent back from the hospitals to 
a central location. At the central location, the models are 
combined to form a model that has been trained on all data. 
In this work, we show that it is possible to train a Bayesian 
network using distributed learning on data from multiple 
